• Immutep, Monash University won ARC Linkage Projects funding of A$652,248 over three years for LAG-3 research.
• Grant supports a Monash-led project studying LAG-3 immune regulation, including evaluation of Immutep’s IMP761 agonist antibody.
• Immutep will also contribute funding from its research budget; company said the amounts are not material.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immutep Ltd. published the original content used to generate this news brief on October 14, 2026, and is solely responsible for the information contained therein.